Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionTwin Tree Management, LP
Latest Disclosed Ownership7,769 shares
Latest Disclosed Value $ 3,469,169
Twin Tree Management, LP ownership in VRTX / Vertex Pharmaceuticals Incorporated

On May 14, 2026 - Twin Tree Management, LP filed a 13F-HR form disclosing ownership of 7,769 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $3,469,169 USD as of March 31, 2026. The entity filed a previous 13F-HR on July 28, 2025 disclosing 0 shares of Vertex Pharmaceuticals Incorporated. The current value of the position is $3,431,878 USD.

Twin Tree Management, LP has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 12,000 of underlying shares valued at $5,358,480 USD and put options representing 26,800 of underlying shares valued at $11,967,272 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 7,769 7,769 3,469 0.0731
2025-07-28 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -8,773 -100.00 0 -100.00
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 8,773 8,773 4,253 0.0080
2024-11-13 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -11,661 -100.00 0 -100.00
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,661 11,661 5,466 0.0123
2024-05-09 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -129,852 -100.00 0 -100.00
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 129,852 49,532 61.67 52,835 89.17 0.1009
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 80,320 52,863 192.53 27,930 189.07 0.0628
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 27,457 27,457 9,662 0.0148
2023-05-10 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -11,540 -100.00 0 -100.00
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,540 -17,654 -60.47 3,333 -60.58 0.0072
2022-11-10 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 29,194 27,366 1,497.05 8,453 1,541.36 0.0162
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,828 -134,763 -98.66 515 -98.56 0.0008
2022-05-11 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 136,591 -4,228 -3.00 35,646 15.27 0.0570
2022-02-10 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 140,819 122,616 673.60 30,924 836.52 0.0643
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 18,203 7,344 67.63 3,302 50.78 0.0073
2021-08-12 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 10,859 -32,408 -74.90 2,190 -76.45 0.0059
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 43,267 43,203 67,504.69 9,298 61,886.67 0.0347
2021-02-12 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 64 64 15 0.0001
2020-11-13 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -17,608 -100.00 0 -100.00
2020-08-12 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 17,608 6,398 57.07 5,112 91.68 0.0208
2020-05-13 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,210 -23,410 -67.62 2,667 -64.82 0.0128
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 34,620 28,311 448.74 7,580 609.07 0.0263
2019-11-12 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,309 -2,542 -28.72 1,069 -34.13 0.0042
2019-08-12 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 8,851 -5,953 -40.21 1,623 -40.40 0.0079
2019-05-10 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 14,804 14,804 2,723 0.0141
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -36,049 -100.00 0 -100.00
2018-11-09 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 36,049 18,440 104.72 6,948 132.14 0.0473
2018-08-07 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 17,609 16,505 1,495.02 2,993 1,562.78 0.0184
2018-05-09 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,104 -49,050 -97.80 180 -97.61 0.0014
2018-02-09 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 50,154 322 0.65 7,516 -0.79 0.0557
2017-11-13 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 49,832 49,832 7,576 0.0600
2016-09-14 2013-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 0 -10,729 -100.00 0 -100.00
2016-09-14 2013-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 10,729 1,878 21.22 590 59.03 0.0293
2013-08-14 2013-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 10,729 590
2016-09-14 2012-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 8,851 8,851 371 0.0321
2013-08-14 2012-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 8,851 371 0.4562
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS COM Call 12,000 -22.08 5,358 -23.25 n/a n/a n/a
2026-02-11 2025-12-31 13F VERTEX PHARMACEUTICALS COM Call 15,400 -48.67 6,982 -40.58 n/a n/a n/a
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM Call 30,000 -72.25 11,749 -75.59 n/a n/a n/a
2025-07-28 2025-06-30 13F VERTEX PHARMACEUTICALS COM Call 108,100 48,126 n/a n/a n/a
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS ORDINARY SHARES Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-10 2024-12-31 13F VERTEX PHARMACEUTICALS ORDINARY SHARES Call 70,500 840.00 28,390 713.93 n/a n/a n/a
2024-11-13 2024-09-30 13F VERTEX PHARMACEUTICALS COM Call 7,500 3,488 n/a n/a n/a
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-09 2024-03-31 13F VERTEX PHARMACEUTICALS COM Call 27,700 -70.41 11,579 -69.60 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS CALL Call 93,600 38,085 n/a n/a n/a
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-10 2022-09-30 13F VERTEX PHARMACEUTICALS CALL Call 1,900 550 n/a n/a n/a
2022-05-11 2022-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-10 2021-12-31 13F VERTEX PHARMACEUTICALS COM Call 100 22 n/a n/a n/a
2021-08-12 2021-06-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM Call 700 0.00 150 -9.09 n/a n/a n/a
2021-02-12 2020-12-31 13F VERTEX PHARMACEUTICALS COM Call 700 -99.53 165 -99.59 n/a n/a n/a
2020-11-13 2020-09-30 13F VERTEX PHARMACEUTICALS COM Call 147,400 40,110 n/a n/a n/a
2018-08-07 2018-06-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-09 2018-03-31 13F VERTEX PHARMACEUTICALS COM Call 4,200 -10.64 685 -2.70 n/a n/a n/a
2018-02-09 2017-12-31 13F VERTEX PHARMACEUTICALS COM Call 4,700 487.50 704 477.05 n/a n/a n/a
2017-11-13 2017-09-30 13F VERTEX PHARMACEUTICALS COM Call 800 122 n/a n/a n/a
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-09-14 2014-09-30 13F/A VERTEX PHARMACEUTICALS COM Call 700 0.00 79 n/a n/a n/a
2016-09-14 2013-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-09-14 2013-03-31 13F/A VERTEX PHARMACEUTICALS COM Call 200 -97.85 11 -97.18 n/a n/a n/a
2013-08-14 2013-03-31 13F VERTEX PHARMACEUTICALS COM Call 2 0 n/a n/a n/a
2016-09-14 2012-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 9,300 390 n/a n/a n/a
2013-08-14 2012-12-31 13F VERTEX PHARMACEUTICALS COM Call 93 4 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS COM Put 26,800 5.51 11,967 3.93 n/a n/a n/a
2026-02-11 2025-12-31 13F VERTEX PHARMACEUTICALS COM Put 25,400 -45.49 11,515 -36.90 n/a n/a n/a
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM Put 46,600 36.66 18,250 20.22 n/a n/a n/a
2025-07-28 2025-06-30 13F VERTEX PHARMACEUTICALS COM Put 34,100 -22.68 15,181 -28.99 n/a n/a n/a
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM Put 44,100 732.08 21,381 901.87 n/a n/a n/a
2025-02-10 2024-12-31 13F VERTEX PHARMACEUTICALS ORDINARY SHARES Put 5,300 2,134 n/a n/a n/a
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-09 2024-03-31 13F VERTEX PHARMACEUTICALS COM Put 122,200 -33.00 51,081 -31.17 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS PUT Put 182,400 74,217 n/a n/a n/a
2023-05-10 2023-03-31 13F VERTEX PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS PUT Put 47,300 -0.21 13,659 -0.47 n/a n/a n/a
2022-11-10 2022-09-30 13F VERTEX PHARMACEUTICALS PUT Put 47,400 -13.50 13,724 -11.13 n/a n/a n/a
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS PUT Put 54,800 10.93 15,442 19.78 n/a n/a n/a
2022-05-11 2022-03-31 13F VERTEX PHARMACEUTICALS COM Put 49,400 -28.92 12,892 -15.53 n/a n/a n/a
2022-02-10 2021-12-31 13F VERTEX PHARMACEUTICALS COM Put 69,500 15,262 n/a n/a n/a
2020-05-13 2020-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Put 4,300 941 n/a n/a n/a
2019-08-12 2019-06-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-10 2019-03-31 13F VERTEX PHARMACEUTICALS COM Put 3,500 644 n/a n/a n/a
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-09 2018-09-30 13F VERTEX PHARMACEUTICALS COM Put 19,000 3,662 n/a n/a n/a
2018-05-09 2018-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F VERTEX PHARMACEUTICALS COM Put 101,600 -35.53 15,226 -36.46 n/a n/a n/a
2017-11-13 2017-09-30 13F VERTEX PHARMACEUTICALS COM Put 157,600 23,962 n/a n/a n/a
2016-09-14 2013-06-30 13F/A VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-09-14 2013-03-31 13F/A VERTEX PHARMACEUTICALS COM Put 300 -96.88 16 -96.02 n/a n/a n/a
2013-08-14 2013-03-31 13F VERTEX PHARMACEUTICALS COM Put 3 0 n/a n/a n/a
2016-09-14 2012-12-31 13F/A VERTEX PHARMACEUTICALS COM Put 9,600 402 n/a n/a n/a
2013-08-14 2012-12-31 13F VERTEX PHARMACEUTICALS COM Put 96 4 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.